BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22248476)

  • 21. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A; Martelli E; Bavera P; Agus GB
    Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.
    Wu YJ; Luo SF; Yang SH; Chen JY; Yu KH; See LC
    Chang Gung Med J; 2008; 31(5):492-502. PubMed ID: 19097597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
    Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists for the treatment of Raynaud's phenomenon].
    Müller-Bühl U; Diehm C; Scheuermann W; Mörl H
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1795-7. PubMed ID: 6357692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M; Falcini F; Bartolozzi G; Volpi M
    Int J Clin Pharmacol Res; 1985; 5(1):67-9. PubMed ID: 3997315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
    Finch MB; Dawson J; Johnston GD
    Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does prevalence of migraine and Raynaud's phenomenon also increase in Korean patients with proven variant angina?
    Koh KK; Kim SH; Lee KH; Kwon KS; Kim EJ; Baik SH; Cho SK; Kim SS; Park CO; Chung JK
    Int J Cardiol; 1995 Aug; 51(1):37-46. PubMed ID: 8522395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine and distal gangrene in Raynaud's phenomenon.
    Rivera Redondo J; Noguerado Asensio A; Alvaro-Gracia Alvaro JM; Laffón Roca A
    J Rheumatol; 1986 Apr; 13(2):464-5. PubMed ID: 3723511
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 36. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2005 Jun; (13):1546-54. PubMed ID: 16135302
    [No Abstract]   [Full Text] [Related]  

  • 37. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2004 Dec; (12):1725-34. PubMed ID: 15865744
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
    Codella O; Caramaschi P; Olivieri O; Perbellini L; Perbellini A; Bambara LM; Corrocher R; De Sandre G
    Angiology; 1989 Feb; 40(2):114-21. PubMed ID: 2644876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
    Varela-Aguilar JM; Sánchez-Román J; Talegón Meléndez A; Castillo Palma MJ
    Rev Clin Esp; 1997 Feb; 197(2):77-83. PubMed ID: 9213861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.